ProCE Banner Activity

HBV Reactivation After Switch to ART Lacking HBV Activity: Results in Persons With Hepatitis B Core Antibody Positivity

Conference Coverage
Slideset

In this group of persons living with HIV who were at risk for HBV reactivation, low rates of HBV reactivation were observed after switching to ART that had no anti-HBV activity. 

Released: October 20, 2023

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare